Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

VYGR

Voyager Therapeutics (VYGR)

Voyager Therapeutics Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:VYGR
FechaHoraFuenteTítuloSímboloCompañía
24/04/202508:12Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:VYGRVoyager Therapeutics Inc
23/04/202515:02Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:VYGRVoyager Therapeutics Inc
23/04/202515:02Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:VYGRVoyager Therapeutics Inc
23/04/202515:01Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:VYGRVoyager Therapeutics Inc
04/04/202515:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VYGRVoyager Therapeutics Inc
02/04/202515:11Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VYGRVoyager Therapeutics Inc
31/03/202506:00GlobeNewswire Inc.Voyager Presents Robust Preclinical Data from Tau Targeting Gene Therapy and Antibody Programs at AD/PD™ 2025NASDAQ:VYGRVoyager Therapeutics Inc
11/03/202515:10Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:VYGRVoyager Therapeutics Inc
11/03/202515:01Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:VYGRVoyager Therapeutics Inc
11/03/202515:01GlobeNewswire Inc.Voyager Reports Fourth Quarter and Full Year 2024 Financial and Operating ResultsNASDAQ:VYGRVoyager Therapeutics Inc
11/03/202515:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VYGRVoyager Therapeutics Inc
04/03/202506:00GlobeNewswire Inc.Voyager Therapeutics Announces Fourth Quarter 2024 Conference Call and WebcastNASDAQ:VYGRVoyager Therapeutics Inc
03/03/202506:00GlobeNewswire Inc.Voyager Reports Positive Topline Data for Single Ascending Dose (SAD) Trial of Anti-Tau Antibody VY7523 and Initiates Multiple Ascending Dose (MAD) Trial in Alzheimer’s DiseaseNASDAQ:VYGRVoyager Therapeutics Inc
25/02/202506:00GlobeNewswire Inc.Voyager Therapeutics to Present at Multiple Upcoming Investor ConferencesNASDAQ:VYGRVoyager Therapeutics Inc
11/02/202506:00GlobeNewswire Inc.Voyager Provides Update on SOD1 ALS Gene Therapy ProgramNASDAQ:VYGRVoyager Therapeutics Inc
06/02/202506:00GlobeNewswire Inc.Voyager to Present at Oppenheimer 25th Annual Healthcare Life Sciences ConferenceNASDAQ:VYGRVoyager Therapeutics Inc
20/11/202406:00GlobeNewswire Inc.Voyager Selects Tau Silencing Gene Therapy Development Candidate for Alzheimer’s DiseaseNASDAQ:VYGRVoyager Therapeutics Inc
12/11/202415:01GlobeNewswire Inc.Voyager Reports Third Quarter 2024 Financial and Operating ResultsNASDAQ:VYGRVoyager Therapeutics Inc
05/11/202406:00GlobeNewswire Inc.Voyager Therapeutics Announces Third Quarter 2024 Conference Call and WebcastNASDAQ:VYGRVoyager Therapeutics Inc
16/09/202406:00GlobeNewswire Inc.Voyager Advances Collaboration with Neurocrine; Third Gene Therapy Development Candidate SelectedNASDAQ:VYGRVoyager Therapeutics Inc
05/09/202407:00GlobeNewswire Inc.Voyager Enters into License for Next-Generation Capsid, Bringing Partnered Portfolio of TRACER-Enabled Gene Therapies to 14NASDAQ:VYGRVoyager Therapeutics Inc
29/08/202415:01GlobeNewswire Inc.Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:VYGRVoyager Therapeutics Inc
07/08/202406:00GlobeNewswire Inc.Voyager Therapeutics to Present at Canaccord Genuity 44th Annual Growth Conference & Private Company ShowcaseNASDAQ:VYGRVoyager Therapeutics Inc
06/08/202415:01GlobeNewswire Inc.Voyager Therapeutics Reports Second Quarter 2024 Financial and Operating ResultsNASDAQ:VYGRVoyager Therapeutics Inc
30/07/202406:00GlobeNewswire Inc.Voyager Therapeutics Announces Second Quarter 2024 Conference Call and WebcastNASDAQ:VYGRVoyager Therapeutics Inc
09/07/202415:10Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:VYGRVoyager Therapeutics Inc
13/06/202415:01GlobeNewswire Inc.Voyager Therapeutics to Present at Multiple Virtual Investor ConferencesNASDAQ:VYGRVoyager Therapeutics Inc
13/06/202406:00GlobeNewswire Inc.Voyager Therapeutics Announces Appointment of Nathan Jorgensen as Chief Financial OfficerNASDAQ:VYGRVoyager Therapeutics Inc
16/05/202406:00GlobeNewswire Inc.Voyager Therapeutics Announces First Participants Dosed in Single Ascending Dose Trial of VY-TAU01 for the Treatment of Alzheimer’s DiseaseNASDAQ:VYGRVoyager Therapeutics Inc
13/05/202415:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VYGRVoyager Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:VYGR

Su Consulta Reciente

Delayed Upgrade Clock